IL13 and graft versus host disease: While IL-13 demonstrates protective effects in GVHD animal models, clinical observations reveal a paradoxical association: elevated donor-derived IL-13 levels prior to transplantation strongly predict severe acute GVHD development in patients, suggesting type 2 cytokines (IL-5/IL-13) may critically influence graft outcomes during cytokine storms [181].